Newsletter

Idiopathic pulmonary fibrosis
Substantial growth is expected in the Idiopathic pulmonary fibrosis market size owing to multiple key drivers
IDIOPATHIC PULMONARY FIBROSIS

More Whitepapers / Newsletters

Paroxysmal Nocturnal Hemoglobinuria Newsletter
Paroxysmal Nocturnal Hemoglobi...

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired disease that leads to the destruction of red blood cells, blood clots, and an impaired bone marrow caused due to the mutation in the PIGA (...

Rheumatoid Arthritis Newsletter
Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is an inflammatory disorder that affects an individual's single or multiple joints at the same time. Research has shown that RA is more prevalent in females with around 1-3%...

Automated Insulin Delivery Market
Automated Insulin Delivery

Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of type 1 diabetes. The developments have enabled the automation of insulin delivery, where an algorithm d...

Lamellar Ichthyosis
Lamellar Ichthyosis

Lamellar Ichthyosis (LI) is an autosomal recessive congenital Ichthyosis (ARCI), which mainly affects the skin. It is a clinically and genetically heterogeneous group of dermatological scaly skin diso...

Systemic Scleroderma Market
Systemic Scleroderma

Systemic scleroderma (SSC or systemic sclerosis) is an autoimmune disorder that results into scar tissues (fibrosis) on the skin and internal organs. The prevalence of systemic scleroderma is about 30...